To identify predictive factors of response to viscosupplementation (VS) in patients with hip osteoarthritis (HOA). Methods: Prospective, multicentre, open-label trial, achieved in daily practice conditions. Patients with HOA were treated with a single intra-articular injection of a cross-linked hyaluronic acid combined with mannitol (HAnox-M-XL), using imaging guidance. |